The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans
Abstract
Inhibition of the activity of the human bile salt export pump (BSEP: ABCB11) has been proposed to play a role in drug-induced liver injury (DILI). To enhance understanding of the relationship between BSEP inhibition and DILI, inhibition of human BSEP (hBSEP) and its rat ortholog (rBsep) by 85 pharmaceuticals was investigated in vitro. This was explored using assays that quantified inhibition of ATP-dependent [(3)H]taurocholate uptake into inverted plasma membrane vesicles from Sf21 insect cells, which expressed the proteins. Of the pharmaceuticals, 40 exhibited evidence of in vitro transporter inhibition and overall a close correlation was observed between potency values for inhibition of hBSEP and rBsep activity (r(2) = 0.94), although 12 drugs exhibited >2-fold more potent inhibition of hBSEP than rBsep. The median potency of hBSEP inhibition was higher among drugs that caused cholestatic/mixed DILI than among drugs that caused hepatocellular or no DILI, as was the incidence of hBSEP inhibition with IC(50) <300 μM. All drugs with hBSEP IC(50) <300 μM had molecular weight >250, ClogP >1.5, and nonpolar surface area >180Å. A clear distinction was not evident between hBSEP IC(50) or unbound plasma concentration (C(max, u)) of the drugs in humans and whether the drugs caused DILI. However, all 17 of the drugs with hBSEP IC(50) <100 μM and C(max, u) >0.002 μM caused DILI. Overall, these data indicate that inhibition of hBSEP/rBsep correlates with the propensity of numerous pharmaceuticals to cause cholestatic DILI in humans and is associated with several of their physicochemical properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Strautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E., Dahan, K., Childs, S., Ling, V., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 995
Bile-acid-induced cell injury and protection
Perez, M. J., & Briz, O. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1677 · Cited by 717
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
Hepatotoxicity the adverse effects of drugs and other chemicals on the liver
Zimmerman, H. J. (1999) · Cited by 514
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468
Kartenbeck, J., Leuschner, U., Mayer, R., & Keppler, D. (1996) · Hepatology · doi:10.1002/hep.510230519 · Cited by 398
Cited by
Items 101–200 of 349
Barber, J., Stahl, S. H., Summers, C., Barrett, G., Park, B. K., Foster, J. R., & Kenna, J. G. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv159 · Cited by 45
Self-citationSusukida, T., Sekine, S., Nozaki, M., Tokizono, M., & Ito, K. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065425 · Cited by 45
Welch, M. A., Köck, K., Urban, T. J., Brouwer, K. L. R., & Swaan, P. W. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062539 · Cited by 44
The chemical, genetic and immunological basis of idiosyncratic drug–induced liver injury
Tailor, A., Faulkner, L., Naisbitt, D. J., & Park, B. K. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115606529 · Cited by 44
Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures
Rodrigues, R. M., Kollipara, L., Chaudhari, U., Sachinidis, A., Zahedi, R. P., Sickmann, A., Kopp‐Schneider, A., Jiang, X., Keun, H. C., Hengstler, J. G., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2214-z · Cited by 44
Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction
Auxtero, M. D., Chalante, S., Abade, M. R., Jorge, R., & Fernandes, A. I. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010124 · Cited by 44
Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid–Mediated DILI
Woodhead, J. L., Yang, K., Brouwer, K. L. R., Siler, S., Stahl, S. H., Ambroso, J. L., Baker, D., Watkins, P. B., & Howell, B. A. (2014) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2014.21 · Cited by 43
Self-citationMacitentan Does Not Interfere with Hepatic Bile Salt Transport
Treiber, A., Äänismaa, P., de Kanter, R., Delahaye, S., Treher, M., Hess, P., & Sidharta, P. N. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214106 · Cited by 43
Ni, X., Gao, Y., Wu, Z., Ma, L., Chen, C., Wang, L., Lin, Y., Hui, L., & Pan, G. (2016) · Scientific Reports · doi:10.1038/srep38694 · Cited by 42
Wu, Z., Qi, X.-M., Sheng, J.-J., Ma, L., Ni, X., Ren, J., Huang, C., & Pan, G. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.65 · Cited by 42
Linton, K. J. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150132 · Cited by 42
Gill, M. W., Murphy, B. J., Cheng, P. T. W., Sivaraman, L., Davis, M., & Lehman-McKeeman, L. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115885 · Cited by 41
Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes
Kastrinou‐Lampou, V., Poller, B., Huth, F., Fischer, A., Kullak-Ublick, G. A., Arand, M., Schadt, H. S., & Camenisch, G. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105533 · Cited by 41
Sistare, F. D., Mattes, W. B., & LeCluyse, E. L. (2016) · ILAR Journal · doi:10.1093/ilar/ilw025 · Cited by 40
Wu, L., Liu, Z., Auerbach, S. S., Huang, R., Chen, M., McEuen, K., Xu, J., Fang, H., & Tong, W. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00719 · Cited by 40
Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity
Pan, G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_6 · Cited by 40
Human leukocyte antigen and idiosyncratic adverse drug reactions
Usui, T., & Naisbitt, D. J. (2016) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2016.11.003 · Cited by 39
Parmentier, C., Couttet, P., Wolf, A., Zaccharias, T., Heyd, B., Bachellier, P., Uteng, M., & Richert, L. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1930-0 · Cited by 39
Montanari, F., Knasmuller, B., Kohlbacher, S. M., Hillisch, C., Baierová, C., Grandits, M., & Ecker, G. F. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00899 · Cited by 39
Guyot, C., Hofstetter, L., & Stieger, B. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.092262 · Cited by 39
Vieira, M. D. L. T., & Tagliati, C. A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.884069 · Cited by 38
Flagging Drugs That Inhibit the Bile Salt Export Pump
Montanari, F., Pinto, M., Khunweeraphong, N., Wlcek, K., Sohail, M. I., Noeske, T., Boyer, S. K., Chiba, P., Stieger, B., Kuchler, K., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00594 · Cited by 37
Cheng, Y., Woolf, T. F., Gan, J., & He, K. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.029 · Cited by 36
Paola, R. D., Modafferi, S., Siracusa, R., Cordaro, M., D’Amico, R., Ontario, M. L., Interdonato, L., Salinaro, A. T., Fusco, R., Impellizzeri, D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084429 · Cited by 36
Jain, S., Grandits, M., Richter, L., & Ecker, G. F. (2017) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-017-0021-x · Cited by 35
Yucha, R. W., He, K., Shi, Q., Cai, L., Nakashita, Y., Xia, C. Q., & Liao, M. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx060 · Cited by 35
Ritschel, T., Hermans, S. M. A., Schreurs, M., van den Heuvel, J. J. M. W., Koenderink, J. B., Greupink, R., & Rüssel, F. G. M. (2014) · Chemical Research in Toxicology · doi:10.1021/tx5000393 · Cited by 34
Jackson, J. P., Freeman, K., Friley, W. W., Claire, R. L. S., Black, C., & Brouwer, K. R. (2016) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0023 · Cited by 34
Chen, X., Kemas, A. M., Mickols, E., Klein, K., Artursson, P., & Lauschke, V. M. (2024) · Biotechnology Journal · doi:10.1002/biot.202300587 · Cited by 33
A large-scale human toxicogenomics resource for drug-induced liver injury prediction
Bergen, V., Kodella, K. R., Srikrishnan, S., Barrandon, O., Anderson, S., Rogers-Grazado, M., Fowler, C. C., Beyene, H., Robichaud, N., Fulton, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65690-3 · Cited by 33
Fernández-Murga, M. L., Petrov, P., Conde, I., Castell, J. V., Gómez‐Lechón, M. J., & Jover, R. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.07.017 · Cited by 32
Establishment of a Drug-Induced, Bile Acid–Dependent Hepatotoxicity Model Using HepaRG Cells
Susukida, T., Sekine, S., Nozaki, M., Tokizono, M., Oizumi, K., Horie, T., & Ito, K. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.01.013 · Cited by 32
Role of Hepatic Drug Transporters in Drug Development
Liu, H., & Sahi, J. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.703 · Cited by 32
Do In Vitro Assays Predict Drug Candidate Idiosyncratic Drug-Induced Liver Injury Risk?
Kenna, J. G., & Uetrecht, J. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.082719 · Cited by 32
Self-citationMechanisms of Chronic Fialuridine Hepatotoxicity as Revealed in Primary Human Hepatocyte Spheroids
Hendriks, D. F. G., Hurrell, T., Riede, J., van der Horst, M., Tuovinen, S., & Ingelman-Sundberg, M. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz195 · Cited by 29
Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture
Oorts, M., Richert, L., & Annaert, P. (2015) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2015.03.002 · Cited by 29
Jackson, J. P., Freeman, K., Claire, R. L. S., Black, C., & Brouwer, K. R. (2018) · Applied In Vitro Toxicology · doi:10.1089/aivt.2018.0011 · Cited by 29
Ali, I., Welch, M. A., Lu, Y. Y., Swaan, P. W., & Brouwer, K. L. R. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.02.011 · Cited by 28
Oizumi, K., Sekine, S., Fukagai, M., Susukida, T., & Ito, K. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.05.017 · Cited by 28
Chan, R., & Benet, L. Z. (2018) · Toxicology Research · doi:10.1039/c8tx00016f · Cited by 28
Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury
Ogimura, E., Nakagawa, T., Deguchi, J., Sekine, S., Ito, K., & Bando, K. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx091 · Cited by 28
Iron depletion induces hepatic secretion of biliary lipids and glutathione in rats
Prašnická, A., Cermanová, J., Hroch, M., Doleželová, E., Rozkydalová, L., Smutný, T., Carazo, A., Chládek, J., Leníček, M., Nachtigal, P., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.09.003 · Cited by 27
Cepa, S. P., Potter, D., Wong, L., Schutt, L., Tarrant, J. M., Pang, J., Zhang, X., Andaya, R., Salphati, L., Ran, Y., et al. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.11.007 · Cited by 27
Current insights in the complexities underlying drug-induced cholestasis
Deferm, N., Vocht, T. D., Qi, B., Brantegem, P. V., Gijbels, E., Vinken, M., de Witte, P. A. M., Bouillon, T. W., & Annaert, P. (2019) · Critical Reviews in Toxicology · doi:10.1080/10408444.2019.1635081 · Cited by 27
Genetic variations of bile salt transporters
Kubitz, R., Dröge, C., Kluge, S., Stindt, J., & Häussinger, D. (2014) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2014.03.006 · Cited by 26
Antibiotic-induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition
Li, Y., Hafey, M. J., Duong, H., Evers, R., Cheon, K., Holder, D., Galijatovic-Idrizbegovic, A., Sistare, F. D., & Glaab, W. E. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx015 · Cited by 26
Kohara, H., Bajaj, P., Yamanaka, K., Miyawaki, A., Harada, K., Miyamoto, K., Matsui, T., Okai, Y., Wagoner, M. P., & Shinozawa, T. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz229 · Cited by 26
Beaudoin, J. J., Bezençon, J., Sjöstedt, N., Fallon, J. K., & Brouwer, K. L. R. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa052 · Cited by 26
Membrane Vesicle ABC Transporter Assays for Drug Safety Assessment
van Staden, C. J., Morgan, R. E., Ramachandran, B., Chen, Y., Lee, P. H., & Hamadeh, H. K. (2012) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx2305s54 · Cited by 25
In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation
Mirahmad, M., Sabourian, R., Mahdavi, M. R., Larijani, B. A., & Safavi, M. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2064487 · Cited by 24
Testa, A., Dall’Angelo, S., Mingarelli, M., Augello, A., Schweiger, L. F., Welch, A., Elmore, C. S., Sharma, P. K., & Zanda, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.12.008 · Cited by 24
Garzel, B., Zhang, L., Huang, S. M., & Wang, H. (2019) · Current Drug Metabolism · doi:10.2174/1389200220666190709170256 · Cited by 24
Toxicology Paradise: Sorting Out Adverse and Non-adverse Findings in Animal Toxicity Studies
Baldrick, P., Cosenza, M. E., Alapatt, T., Bolon, B. N., Rhodes, M., & Waterson, I. (2020) · International Journal of Toxicology · doi:10.1177/1091581820935089 · Cited by 24
Genetic Determinants of Cholestasis
Hirschfield, G. M. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.12.002 · Cited by 23
Matsunaga, N., Kaneko, N., Staub, A. Y., Nakanishi, T., Nunoya, K., Imawaka, H., & Tamai, I. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067074 · Cited by 23
Guo, C., Yang, K., Brouwer, K. R., Claire, R. L. S., & Brouwer, K. L. R. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.231928 · Cited by 23
Machine Learning Models to Predict Inhibition of the Bile Salt Export Pump
McLoughlin, K., Jeong, C. G., Sweitzer, T. D., Minnich, A., Tse, M. J., Bennion, B. J., Allen, J., Calad-Thomson, S., Rush, T. S., & Brase, J. M. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00950 · Cited by 23
Takemura, A., Izaki, A., Sekine, S., & Ito, K. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.05.016 · Cited by 23
Current Concepts in Drug‐Induced Bile Salt Export Pump (BSEP) Interference
Kenna, J. G. (2014) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx2307s61 · Cited by 22
Self-citationRodrigues, A., Rollison, H. E., Martin, S. W., Sarda, S., Schulz-Utermoehl, T., Stahl, S. H., Gustafsson, F., Eakins, J. A., Kenna, J. G., & Wilson, I. D. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1056-y · Cited by 22
Self-citationHerédi‐Szabó, K., Kis, E., & Krajcsi, P. (2012) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx2304s54 · Cited by 22
Ma, L., Wu, Z., Wang, L., Zhang, X., Wang, J., Chen, C., Ni, X., Lin, Y., Cao, Y., Luan, Y., et al. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.157 · Cited by 22
Ghanem, C. I., & Manautou, J. E. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180221142315 · Cited by 22
Parmentier, C., Hendriks, D. F. G., Heyd, B., Bachellier, P., Ingelman‐Sundberg, M., & Richert, L. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.06.1069 · Cited by 22
Susukida, T., Sekine, S., Ogimura, E., Aoki, S., Oizumi, K., Horie, T., & Ito, K. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.06.004 · Cited by 22
Using Jupyter Notebooks for re-training machine learning models
Smajíć, A., Grandits, M., & Ecker, G. F. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00635-2 · Cited by 21
Yoshikado, T., Takada, T., Yamamoto, H., Tan, J. K., Ito, K., Santa, T., & Suzuki, H. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081752 · Cited by 21
Hafey, M. J., Houle, R., Tanis, K. Q., Knemeyer, I. W., Shang, J., Chen, Q., Baudy, A. R., Monroe, J. J., Sistare, F. D., & Evers, R. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000086 · Cited by 21
Jia, S., Chen, Q., Wu, J., Yao, X., Shao, J., Cheng, X., Zhang, C., Cen, D., Wang, Y., Shen, Z., et al. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153656 · Cited by 21
Burbank, M., Sharanek, A., Burban, A., Mialanne, H., Aerts, H., Guguen‐Guillouzo, C., Weaver, R. J., & Guillouzo, A. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx062 · Cited by 20
Hepatotoxicidad: patrón colestásico inducido por fármacos
Morales-Maya, L., López, N. V., & Maya, O. G. M. (2016) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.71 · Cited by 20
The association of transporter ABCC2 (MRP2) genetic variation and drug-induced hyperbilirubinemia
Huang, Y., Chang, T.-E., Perng, C., & Huang, Y. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000470 · Cited by 20
Horiuchi, S., Kuroda, Y., Oyafuso, R., Komizu, Y., Takaki, T., Maeda, K., & Ishida, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-19469-x · Cited by 20
Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations
Riede, J., Poller, B., Huwyler, J., & Camenisch, G. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074179 · Cited by 20
Li, R., Bi, Y., Vildhede, A. M., Scialis, R. J., Mathialagan, S., Yang, X., Marroquin, L. D., Lin, J., & Varma, M. V. S. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074815 · Cited by 20
Rodríguez-Pérez, R., & Gerebtzoff, G. (2021) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2021.100027 · Cited by 19
Hilpert, J., Groettrup‐Wolfers, E., Kosturski, H., Bennett, L., Barnes, C. L. K., Gude, K., Gashaw, I., Reif, S., Steger‐Hartmann, T., Scheerans, C., et al. (2023) · Drugs in R&D · doi:10.1007/s40268-023-00427-5 · Cited by 19
Griffin, L. M., Watkins, P. B., Perry, C. H., Claire, R. L. S., & Brouwer, K. L. R. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.047225 · Cited by 19
Early Drug-Induced Liver Injury Risk Screening: “Free,” as Good as It Gets
Martin, M. T., Koza‐Taylor, P., Di, L., Watt, E. D., Keefer, C. E., Smaltz, D. J., Cook, J. C., & Jackson, J. P. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac054 · Cited by 18
Cheng, Y., Freeden, C., Zhang, Y., Abraham, P., Shen, H., Wescott, D. M., Humphreys, W. G., Gan, J., & Lai, Y. (2016) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2011 · Cited by 18
Ryan, J., Morgan, R. E., Chen, Y., Volak, L. P., Dunn, R. T., & Dunn, K. W. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.079277 · Cited by 18
Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors
Stephens, C., Lucena, M. I., & Andrade, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64089-8 · Cited by 16
Jain, S., & Ecker, G. F. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9420-5_26 · Cited by 16
Using quantitative intravital multiphoton microscopy to dissect hepatic transport in rats
Dunn, K. W., & Ryan, J. (2017) · Methods · doi:10.1016/j.ymeth.2017.04.015 · Cited by 16
Urbán, L., Maciejewski, M., Lounkine, E., Whitebread, S., Jenkins, J. L., Hamon, J., Fekete, A., & Muller, P. Y. (2014) · Toxicology Research · doi:10.1039/c4tx00077c · Cited by 16
Burban, A., Sharanek, A., Humbert, L., Eguether, T., Guguen‐Guillouzo, C., Rainteau, D. P., & Guillouzo, A. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz009 · Cited by 15
Sohail, M. I., Schmid, D., Wlcek, K., Spork, M., Szakács, G., Trauner, M., Stockner, T., & Chiba, P. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.108688 · Cited by 15
Ghanem, C. I., & Manautou, J. E. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000450 · Cited by 14
Takahashi, K., Yoshisue, K., Chiba, M., Nakanishi, T., & Tamai, I. (2017) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2110 · Cited by 14
Predicting drug-induced cholestasis: preclinical models
Petrov, P., Fernández-Murga, M. L., López-Riera, M., Gómez-Lechón, M. J., Castell, J. V., & Jover, R. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1487399 · Cited by 14
Yang, F., Takeuchi, T., Tsuneyama, K., Yokoi, T., & Oda, S. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz088 · Cited by 14
Hepatic drug transporters: the journey so far
Riley, R. J., Foley, S. A., Barton, P., Soars, M. G., & Williamson, B. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1132308 · Cited by 14
Cholangiocyte organoids to study drug-induced injury
Wang, Z., Xing, C., van der Laan, L. J. W., Verstegen, M. M. A., Spee, B., & Masereeuw, R. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03692-6 · Cited by 13
In vitro test battery for testing molecular initiating events in chemical-induced cholestasis
Maerten, A., Drees, A., Jiang, J., Sanz-Serrano, J., Devisscher, L., & Vinken, M. (2025) · Toxicology · doi:10.1016/j.tox.2025.154210 · Cited by 13
Maeda, K. (2020) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2019.12.004 · Cited by 13
Zhou, L., Pang, X., Jiang, J., Zhong, D., & Chen, X. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074104 · Cited by 13
Drug-induced cholestasis assay in primary hepatocytes
Brantegem, P. V., Chatterjee, S., Bruyn, T. D., Annaert, P., & Deferm, N. (2020) · MethodsX · doi:10.1016/j.mex.2020.101080 · Cited by 13
Lapham, K., Novak, J. J., Marroquin, L. D., Swiss, R. L., Qin, S., Strock, C. J., Scialis, R. J., Aleo, M. D., Schroeter, T., Eng, H. F., et al. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00262 · Cited by 12
In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk
Norona, L. M., Fullerton, A. M., Lawson, C., Leung, L., Brumm, J., Kiyota, T., Maher, J. M., Khojasteh, C., & Proctor, W. R. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02804-4 · Cited by 12
Qiu, L., Finley, J. E., Taimi, M., Aleo, M. D., Strock, C., Gilbert, J., Qin, S., & Will, Y. (2015) · Applied In Vitro Toxicology · doi:10.1089/aivt.2015.0014 · Cited by 12
Metadata
- Authors
- Dawson, S., Stahl, S., Paul, N., Barber, J., & Kenna, J. G.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 40
- Issue
- 1
- Pages
- 130-138
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2134837921
- Semantic Scholar
- 60ba71aac3cdfdcd69699825099b32f2949b1f89
- Cited by
- 343
- References
- 49
- Citations by year
- 2026: 18 · 2025: 13 · 2024: 10 · 2023: 9 · 2022: 20 · 2021: 16 · 2020: 20 · 2019: 25 · 2018: 25 · 2017: 43 · 2016: 40 · 2015: 27 · 2014: 28 · 2013: 35 · 2012: 13
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Drug Metabolism and Disposition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- bile salt export pump, ABCB11, drug-induced liver injury, cholestatic liver injury, transporter inhibition, taurocholate uptake, physicochemical properties, drug safety prediction, hepatotoxicity
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily B, Member 11, Animals, Bile Acids and Salts, Cell Line, Cholestasis, Humans, Insecta, Risk Factors, ATP-Binding Cassette Transporters, Rats, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.